Evidence Hub

Case Report: Metastatic right ventricular tumor and pulmonary embolism from cervical cancer post COVID-19 infection

Yang Y, Zhu X, Hu D

Frontiers in immunology, 2026

Abstract

The intracavitary cardiac metastasis from squamous cell carcinoma of the uterine cervix combined with pulmonary embolism is extremely rare, with mean survival less than six months. We report a case of a 52-year-old female with stage IVB cervical squamous cell carcinoma (SCC) and cardiac metastasis presented with exertional dyspnea and chest pain concerning pulmonary embolism (PE) post COVID-19 infection. After empirical anticoagulation and anti-infective therapy, the intracardiac mass and pulmonary embolism persisted. Subsequent PET-CT and histopathological examination revealed advanced cervical squamous cell carcinoma with suspected tumor thrombus involving the right heart and pulmonary artery. Given extensive metastatic disease and high bleeding risk, the multidisciplinary team discussed individualized systemic therapy and suggested conservative management. The patient survived 14 months after diagnosis.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free